Gareth Pryce
London, ENG E12AT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration.
Journal: Science advances
Published: July 10, 2024
Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 23, 2023
The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination.
Journal: Multiple sclerosis and related disorders
Published: August 25, 2022
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis.
Journal: Neuropathology and applied neurobiology
Published: December 14, 2021
Antigen-specific tolerization in human autoimmunity: Inhibition of interferon-beta1a anti-drug antibodies in multiple sclerosis: A case report.
Journal: Multiple sclerosis and related disorders
Published: June 24, 2021
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.
Journal: Clinical and experimental immunology
Published: June 18, 2020
The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: March 14, 2020
Detecting and predicting neutralization of alemtuzumab responses in MS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 10, 2020
The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies.
Journal: Frontiers in immunology
Published: October 29, 2019
Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis.
Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis.
Journal: European journal of neurology
Published: May 17, 2019
Potential mechanisms of action related to the efficacy and safety of cladribine.
Journal: Multiple sclerosis and related disorders
Published: January 03, 2019
Last Updated: 09/26/2026